9-[2-[2-cyano-5-[4-(3-cyanocarbazol-9-yl)phenyl]phenyl]phenyl]carbazole-2-carbonitrile
C45H25N5 — CID 155080988
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[2-[2-cyano-5-[4-(3-cyanocarbazol-9-yl)phenyl]phenyl]phenyl]carbazole-2-carbonitrile
9-[2-[2-cyano-5-[4-(3-cyanocarbazol-9-yl)phenyl]phenyl]phenyl]carbazole-2-carbonitrile (PubChem CID 155080988) has the molecular formula C45H25N5 and a molecular weight of 635.73 g/mol. Its IUPAC name is 9-[2-[2-cyano-5-[4-(3-cyanocarbazol-9-yl)phenyl]phenyl]phenyl]carbazole-2-carbonitrile.
Molecular Properties
| Compound Name | 9-[2-[2-cyano-5-[4-(3-cyanocarbazol-9-yl)phenyl]phenyl]phenyl]carbazole-2-carbonitrile |
|---|---|
| PubChem CID | 155080988 |
| Molecular Formula | C45H25N5 |
| Molecular Weight | 635.73 g/mol |
| Exact Mass | 635.21 |
| IUPAC Name | 9-[2-[2-cyano-5-[4-(3-cyanocarbazol-9-yl)phenyl]phenyl]phenyl]carbazole-2-carbonitrile |
| SMILES | N#Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccc(C#N)c(-c3ccccc3-n3c4ccccc4c4ccc(C#N)cc43)c2)cc1 |
| InChI | InChI=1S/C45H25N5/c46-26-29-14-22-44-40(23-29)37-9-3-4-10-41(37)49(44)34-19-17-31(18-20-34)32-15-16-33(28-48)39(25-32)36-8-2-6-12-43(36)50-42-11-5-1-7-35(42)38-21-13-30(27-47)24-45(38)50/h1-25H |
| InChIKey | CBTNDNJGJUTLFT-UHFFFAOYSA-N |
| XLogP | 10.83 |
| TPSA | 81.23 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 635.73 |
| LogP ≤ 5 | 10.83 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155080988 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.